Dolby Laboratories (DLB) Tops Q3 EPS by 8c, Issues Mixed Q4 Outlook

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.73, $0.08 better than the analyst estimate of $0.65. Revenue for the quarter came in at $305.7 million versus the consensus estimate of $296.89 million.

GUIDANCE:

Dolby Laboratories sees Q4 2017 EPS of $0.36-$0.42, versus the consensus of $0.31. Dolby Laboratories sees Q4 2017 revenue of $230-250 million, versus the consensus of $251.67 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Worried the AI trade has gone too far? Evercore likes these 4 stocks